Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Janet Owens-Grillo"'
Publikováno v:
Journal of Comparative Effectiveness Research, Vol 12, Iss 9 (2023)
What is this summary about? This is a plain language summary of an article originally published in the Journal of Urology. Overactive bladder (also called OAB) has been treated with the same type of medicine for more than 40 years. Vibegron is in
Externí odkaz:
https://doaj.org/article/90fd7b92e43642c2bbbd1fc21a367472
Autor:
Jeffrey Frankel, David Staskin, Susann Varano, Diane K Newman, Steven G Gregg, Janet Owens-Grillo
Publikováno v:
Journal of Comparative Effectiveness Research, Vol 12, Iss 9 (2023)
What is this summary about? This is a plain language summary of an article published in the journal Advances in Therapy. In 2020, the US Food and Drug Administration (also called the FDA) approved a medicine called vibegron to treat overactive bl
Externí odkaz:
https://doaj.org/article/5a79a7666370479286ecd44dbbaa6c6b
Autor:
Reshma Shringarpure, David E. Cohen, Eric Lawitz, Eugene R. Schiff, Anita Kohli, Janet Owens-Grillo, Paul J. Pockros, David Shapiro, Paul A. Hellstern, Michael Fuchs, Leigh MacConell, Courtney Van Biene, Bradley Freilich
Publikováno v:
Liver International. 39:2082-2093
Background & aims Nonalcoholic steatohepatitis (NASH) is a chronic and severe form of nonalcoholic fatty liver disease that can progress to cirrhosis and hepatocellular carcinoma and is a risk factor for cardiovascular disease. Although NASH has no a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9c48f3dcc5c11cf24255e04b416eb24d
https://doi.org/10.1111/liv.14209
https://doi.org/10.1111/liv.14209